Description
WHOLE BLOOD AND BLOOD PRODUCTS
First action · last action
2010-06-26 · 2011-04-26
Transactions
11
First transaction's obligation
$1,207,304
Base + all options value (sum of deltas)
$1,652,094
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-06-26+$1,207,304= $1,207,304
- Mod 12010-12-29+$0= $1,207,304
- Mod 22011-01-21+$120,000= $1,327,304
- Mod 0001A2011-01-31-$56,140= $1,271,165
- Mod 0003A2011-02-25+$180,000= $1,451,165
- Mod 32011-02-25+$0= $1,451,165
- Mod 0004A2011-03-21+$140,000= $1,591,165
- Mod 42011-03-21+$0= $1,591,165
- Mod 0005A2011-04-26+$65,929= $1,657,094
- Mod 0005B2011-04-26-$5,000= $1,652,094
- Mod 52011-04-26+$0= $1,652,094
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-06-26 | +$1,207,304 | $1,207,304 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 1· EXERCISE AN OPTION | 2010-12-29 | +$0 | $1,207,304 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 2· EXERCISE AN OPTION | 2011-01-21 | +$120,000 | $1,327,304 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 0001A· FUNDING ONLY ACTION | 2011-01-31 | −$56,140 | $1,271,165 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 0003A· EXERCISE AN OPTION | 2011-02-25 | +$180,000 | $1,451,165 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 3· EXERCISE AN OPTION | 2011-02-25 | +$0 | $1,451,165 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 0004A· EXERCISE AN OPTION | 2011-03-21 | +$140,000 | $1,591,165 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 4· EXERCISE AN OPTION | 2011-03-21 | +$0 | $1,591,165 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 0005A· FUNDING ONLY ACTION | 2011-04-26 | +$65,929 | $1,657,094 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 0005B· FUNDING ONLY ACTION | 2011-04-26 | −$5,000 | $1,652,094 | WHOLE BLOOD AND BLOOD PRODUCTS |
| Mod 5· EXERCISE AN OPTION | 2011-04-26 | +$0 | $1,652,094 | WHOLE BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q999 from 673-TAMPA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA248BP00880065 | ISLAND COAST ORTHOPEDICS, INC | 673-TAMPA | $0 | FY2012 |
| VA673C20016 | AGENCY FOR COMMUNITY TREATMENT SERVICES, INC | 673-TAMPA | $69,120 | FY2012 |
| VA673C10615 | ACTELION PHARMACEUTICALS US, INC. | 673-TAMPA | $8,796 | FY2011 |
| VA673C10498 | AGENCY FOR COMMUNITY TREATMENT SERVICES, INC | 673-TAMPA | $22,320 | FY2011 |
| VA573C12880 | UNIVERSITY OF FLORIDA | 673-TAMPA | $54,180 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA248P1514_3600_-NONE-_-NONE- · retrieved 2026-09-26.